Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if healing occurs within 21 days of treatment with the use of the CellutomeTM device for fractional epidermal micro grafting compared with standard acellular techniques (creams and membrane dressings). Healing will be determined by time to ≥90% epithelialization within 21 days of treatment. Cosmesis (as assessed by Vancouver Scar Scale (VSS), Patient Observer Scar Assessment Scale (POSAS), erythema, pigmentation, elasticity, thickness, and sensation) will be compared to standard techniques without application of skin cells (epidermal grafts = acellular) and will be measured twelve months post treatment application, ± 6 months.


Clinical Trial Description

Hypothesis: The use of epidermal blister grafting by the CellutomeTM device in the treatment of superficial and mid-dermal burn wounds will demonstrate a difference in time to healing compared to burn wounds treated with standard acellular technique. Primary objective: Determine if the use of the CellutomeTM device will demonstrate a difference in healing time compared to standard acellular technique. Final cosmetic outcomes (as assessed by Vancouver Scar Scale (VSS), Patient Observer Scar Assessment Scale (POSAS), erythema, pigmentation, elasticity, thickness, and sensation) will be assessed and described at 12 months ± 6 months post treatment. Secondary objectives: - Determine if donor sites have any visible scarring with the use of the CellutomeTM. - Determine acute outcomes of therapy such as time to healing as assessed by ≥90% epithelialization. - Determine chronic outcomes of therapy (as assessed by Vancouver Scar Scale (VSS), Patient Observer Scar Assessment Scale (POSAS), erythema, pigmentation, elasticity, thickness, and sensation). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02982096
Study type Interventional
Source Lehigh Valley Hospital
Contact
Status Completed
Phase N/A
Start date August 23, 2016
Completion date December 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03948360 - Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds N/A
Completed NCT04277182 - Effect of Propolis Application on Burn Healing N/A
Enrolling by invitation NCT00978705 - Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood Phase 3
Withdrawn NCT03675568 - Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment N/A
Active, not recruiting NCT04828304 - PLASOMA Ultimate Safety & Efficacy Study N/A
Not yet recruiting NCT05649332 - Study to Evaluate the Performance and Safety of the Medical Device Argogen N/A
Recruiting NCT05593523 - Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes
Completed NCT06280053 - HealiAid in the Treatment of Different Wounds N/A
Enrolling by invitation NCT06103409 - MSCs for the Treatment of Burn Wounds Phase 1/Phase 2
Recruiting NCT05796492 - Ultrasound Treatment on Wound Healing Time N/A
Enrolling by invitation NCT04725071 - Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults N/A
Suspended NCT02577120 - Wound Healing Endpoint and Recurrence Phase 4
Active, not recruiting NCT05341427 - DEVELOPMENT OF A CLINICAL PREDICTION RULES TO IDENTIFY EFFICACY OF PULSED ELECTROMAGNETIC THERAPY ON BURN WOUND HEALING N/A
Completed NCT04753723 - The Use of a Platform Wound Device for Reducing Infection Phase 4
Terminated NCT03723590 - A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG N/A
Not yet recruiting NCT04011306 - A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns N/A
Recruiting NCT05404191 - Prediction Rules for Low Level Laser on Burn Wounds N/A